Together Overcoming Diabetes for Diabetes
Recruiting in Palo Alto (17 mi)
DW
Overseen byDonald Warne, MD, MPH
Age: Any Age
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Johns Hopkins Bloomberg School of Public Health
Trial Summary
What is the purpose of this trial?
The goal of this research is to evaluate a scientifically rigorous diabetes intervention, Together Overcoming Diabetes (TOD), that has been tailored to address the unique underlying risk and protective factors and social determinants of diabetes among American Indian/Alaska Native (AI/AN) populations.
Research Team
DW
Donald Warne, MD, MPH
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for American Indian/Alaska Native individuals who have diabetes. Specific eligibility details are not provided, but typically participants would need to meet certain health criteria and be willing to follow the study procedures.Inclusion Criteria
Adult Index Participants: Self-identifies as American Indian or Alaska Native
Adult Index Participants: Rapid City-based participants who reside within 1 hour transportation range of the Oyate Health Center
I am between 10 and 25 years old.
See 9 more
Exclusion Criteria
I am able to fully participate without any planned interruptions.
I am willing to be a support person for another adult in the study.
Adult Index Participants: Has a circumstance that might impact successful participation based on provider judgment considering instances where diabetes control can become more difficult with advanced disease or special conditions including: pregnant, nursing, or planning to become pregnant, end-stage renal disease on dialysis, diabetes due to secondary causes such as Cushing's or Cystic Fibrosis, or any condition that may inhibit participation
See 2 more
Treatment Details
Interventions
- TOD Great Plains (Behavioral Intervention)
Trial OverviewThe study tests a tailored diabetes intervention called Together Overcoming Diabetes (TOD) against a waitlist standard of care in AI/AN populations. The effectiveness of TOD in managing diabetes will be compared with those receiving usual care.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Together Overcoming Diabetes InterventionExperimental Treatment1 Intervention
Together Overcoming Diabetes curriculum adapted for Lakota caregivers and the caregivers families
Group II: Waitlist Standard of CarePlacebo Group1 Intervention
Participants who are waitlisted to receive the TOD intervention will receive Standard of Care.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Center for Indigenous Health - Great Plains HubRapid City, SD
Loading ...
Who Is Running the Clinical Trial?
Johns Hopkins Bloomberg School of Public Health
Lead Sponsor
Trials
441
Patients Recruited
2,157,000+
The NIH Community Engagement Alliance
Collaborator
Trials
1
Patients Recruited
80+
Oyate Health Center
Collaborator
Trials
1
Patients Recruited
80+
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Trials
3987
Patients Recruited
47,860,000+